VIM and interstitial lung disease: In the present work, several novel antigen peptides bearing these three PTMs relevant for RA but considering other proteins that are present in the rheumatoid synovial tissue, such as alpha-enolase or vimentin, have been designed and synthesized trying to address the still unmet need of identifying those RA patients who will develop ILD.